Company news

CelLBxHealth plc news in 2017

CelLBxHealth plc's news releases, calls and decks from 2017, newest first.

View company

Transfer of Lock-in Shares

December 12, 2017

Parsortix potential in metastatic breast cancer

December 8, 2017

Parsortix enables CTC molecular characterisation

November 28, 2017

Philips collaboration in breast and rectal cancer

November 23, 2017

Total Voting Rights and Covington Subscription

November 16, 2017

ANGLE: Completion of Fundraising and Acquisition

November 1, 2017

Total Voting Rights

October 26, 2017

Parsortix harvests cancer cells from bone marrow

October 23, 2017

ANGLE: 7th Peer Reviewed Publication On Parsortix

October 17, 2017

Proposed further subscription for £2.8 million

October 12, 2017

CTCs harvested with Parsortix grown in laboratory

October 9, 2017

Acquisition and Fundraising

October 5, 2017

Exclusive worldwide option over megakaryocyte IP

September 13, 2017

Co-Marketing Partnership with QIAGEN

September 11, 2017

New Research with Parsortix

September 4, 2017

Preclinical Study Presented At Tumor Boston Summit

July 20, 2017

Successful Headline Data in Ovarian Cancer Studies

July 4, 2017

Parsortix breakthrough in prostate cancer

June 15, 2017

Success with Parsortix in Colorectal Cancer

June 5, 2017

Parsortix enables analysis in head and neck cancer

April 3, 2017

Prostate Cancer Update

March 30, 2017

Selected for European Cancer ID Programme

February 13, 2017

Interim Evaluation of Ovarian Cancer Study

January 26, 2017

Decks in 2017